TABLE 1.
Gene | HR | HR.95L | HR.95H | p a |
---|---|---|---|---|
CP | 1.005 | 1.001 | 1.010 | 0.011 |
CAV1 | 1.004 | 1.001 | 1.007 | 0.009 |
ATF3 | 1.007 | 1.001 | 1.013 | 0.025 |
HELLS | 0.875 | 0.797 | 0.961 | 0.005 |
PLIN2 | 1.013 | 1.001 | 1.026 | 0.030 |
TFRC | 0.999 | 0.997 | 1.000 | 0.036 |
RRM2 | 0.987 | 0.976 | 0.999 | 0.032 |
MUC1 | 1.003 | 1.000 | 1.006 | 0.022 |
ARRDC3 | 1.011 | 1.001 | 1.020 | 0.029 |
ACSL5 | 1.015 | 1.002 | 1.029 | 0.021 |
DUSP1 | 1.002 | 1.001 | 1.003 | 0.007 |
JUN | 1.004 | 1.001 | 1.007 | 0.004 |
EPAS1 | 1.005 | 1.000 | 1.009 | 0.032 |
ROS1 | 1.040 | 1.012 | 1.06 | 0.004 |
MAP1LC3C | 1.236 | 1.076 | 1.420 | 0.003 |
ENPP2 | 1.022 | 1.001 | 1.044 | 0.037 |
ALOX5 | 1.017 | 1.004 | 1.029 | 0.008 |
TP63 | 0.997 | 0.994 | 1.000 | 0.028 |
SLC39A8 | 1.020 | 1.006 | 1.035 | 0.006 |
SLC7A5 | 1.002 | 1.000 | 1.005 | 0.030 |
Abbreviations: HR, hazard ratio; LUSC, lung squamous cell carcinoma.
p‐values were obtained from the univariate Cox regression analysis of overall survival (OS) in The Cancer Genome Atlas (TCGA) cohort.